Olema Insider Sell‑Off: What It Signals for Investors Amid Pipeline Uncertainty
Insider selling at Olema Pharmaceuticals signals a hedge‑strategy, not a crash; investors should weigh the biotech’s women’s‑cancer pipeline, market rally, and future trials before acting.
3 minutes to read